Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. - Wikidata - wikimedia - TriplyDB

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.

http://www.wikidata.org/entity/Q36346927

about

MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.Gankyrin regulates cell signaling network.Gankyrin as a potential therapeutic target for cancer.Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma

P2860

Q36781132-AAE3D3C0-8078-42D2-AD4A-B9F8FD42FAD3 Q37701508-E98ABFDC-8ACB-4453-848E-13662CEE8A59 Q37743491-F3A993B1-C8EE-46D5-A394-D0E19D1FC37E Q38714564-46D85870-F0CF-40A6-87A5-DDD49A405B6B Q39319386-FE908F00-C3B7-4FCD-B4AB-0A789E6CC9F9 Q47661011-ED76B7C3-C1CF-41D1-BCCB-6B7F14150DE3 Q47793229-E631C63C-3808-475D-B65C-414BD14C4DA1 Q48118614-65A1F2AF-2187-4F6B-966D-9A436A52CF5F Q57144042-5F29CBCB-38F9-497A-9656-8A91135CFF46

P2860

Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.

http://www.wikidata.org/entity/Q36346927

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@ast

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@en

type

label

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@ast

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@en

prefLabel

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@ast

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@en

P1433

Q36346927-33A267F3-C5BC-441C-BCF7-105171DE12C7

P1476

Q36346927-33800420-8059-4F8C-90E0-8F88002E8CFD

P2093

Q36346927-00963AC2-B894-4217-B91F-23B2A1AE78F3

Q36346927-0DE22992-B0F4-4D79-B092-667F1D7DBD61

Q36346927-20E153E8-A1B3-4CD1-997D-B6438F050D4F

Q36346927-39551FB7-F870-43A3-958F-7D49D867E8A9

Q36346927-54A37616-200A-41C1-BF2F-6A8A17FCC024

Q36346927-58FEADF1-F64F-441E-B959-549241635BBC

Q36346927-70315FAB-19A4-4143-A80E-710489B044F8

Q36346927-8A80180E-AFB2-491C-96E4-E1A77A1170F2

Q36346927-8BCA6CCB-6E37-4589-B0F3-ADDCB95D6525

Q36346927-911C523A-C828-4F82-8A7C-3941E7EC4C57

P2860

Q36346927-0261D999-7D89-4CB2-99CB-DAE38AE939A4

Q36346927-044A7005-57C2-44D1-B8FB-366CE00A773F

Q36346927-080F4F0D-75A4-4ADC-86A5-AF09DC543CA9

Q36346927-08BD5DB1-7FA7-4F6B-B60C-2EDB097C2FC2

Q36346927-1889E004-12F7-4BD0-A699-D3374E331D70

Q36346927-189827D8-66D4-44B7-8EE3-FAD11ED3119C

Q36346927-21D6FF81-BF5B-434F-BD53-80A46D70E8A4

Q36346927-320F940A-264A-47AA-99E3-D7605F82E1D2

Q36346927-34BE8010-36B1-4BE8-998A-A2E2F2BEFEB2

Q36346927-37247D61-26E7-4946-AF7F-266B25A1410A

P304

Q36346927-C40E394C-C5B2-4A58-9636-E36CCA4DF620

P31

Q36346927-216BB450-7DF1-4D0A-85B5-5C0F0616C418

P356

Q36346927-5C60F352-8280-47B6-B9FA-3312534A4BBB

P478

Q36346927-FBA469F6-EB8C-4B2D-9707-89DA710D1921

P577

Q36346927-638CF1D6-B162-4572-B4A7-1502EB863A9A

P5875

Q36346927-A933A4CF-E58E-42C9-A059-A2D3F2F8CC38

P698

Q36346927-88852FD6-B879-4FC2-84FA-3CEB8A4E0338

P932

Q36346927-43C69FDC-4A18-463B-8737-3D1B62262FD0

P356

P1433

Cell Death and Disease

P1476

Gankyrin drives malignant tran ...... osis via the Rac1/JNK pathway.

@en

P2093

A Xu

http://www.w3.org/2001/XMLSchema#string

B Su

http://www.w3.org/2001/XMLSchema#string

B Wang

http://www.w3.org/2001/XMLSchema#string

H Wang

http://www.w3.org/2001/XMLSchema#string

J Fu

http://www.w3.org/2001/XMLSchema#string

J Jiang

http://www.w3.org/2001/XMLSchema#string

J Zhu

http://www.w3.org/2001/XMLSchema#string

L Yu

http://www.w3.org/2001/XMLSchema#string

N Li

http://www.w3.org/2001/XMLSchema#string

R Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

Inflammation and cancer

The therapeutic value of targeting inflammation in gastrointestinal cancers

Rho GTPases in cell biology

Sorafenib in advanced hepatocellular carcinoma

Signal transduction by the JNK group of MAP kinases

Rac activation and inactivation control plasticity of tumor cell movement

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

P304

e1751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2015.120

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276068202

http://www.w3.org/2001/XMLSchema#string

P698

25950481

http://www.w3.org/2001/XMLSchema#string

P932

4669699

http://www.w3.org/2001/XMLSchema#string